Doha, 22 April 2025: Hamad Medical Corporation (HMC) joined the global community in marking World Hemophilia Day on 17 April by highlighting the wide range of advanced services available in Qatar for people with bleeding disorders. The day serves as an important reminder of the need for high-quality care for all individuals affected by hemophilia and related conditions.
HMC provides comprehensive, multidisciplinary care to patients with hemophilia, with over 65 adult patients currently receiving regular care at the National Center for Cancer Care and Research (NCCCR).
Among the services offered at HMC are:
- A weekly multidisciplinary virtual clinic, bringing together hematologists, pharmacists, orthopedic surgeons, physiotherapists, and nurses to coordinate personalized care.
- Access to short half-life (SHL), extended half-life (EHL), and non-replacement therapies - making HMC one of the few centers in the region to offer this full spectrum of prophylactic treatment options.
- A dedicated musculoskeletal clinic at the Bone and Joint Center, combining orthopedic and physiotherapy care for joint health and injury prevention.
HMC is also introducing state-of-the-art treatments, including ultra-long half-life (UHL) therapies, which represent major advances in care for people with hemophilia. These cutting-edge treatments offer hope for better quality of life and reduced bleeding episodes.
Dr. Mohamed Osama Al Homsi, Senior Consultant in Oncology at NCCCR, said: “Hamad Medical Corporation has built one of the most advanced and comprehensive hemophilia services in the region - delivering high-quality, evidence-based care through a dedicated multidisciplinary team. From access to the latest therapies to coordinated long-term management, our focus is always on improving outcomes and enhancing the lives of our patients. We are proud to raise awareness of these services on World Hemophilia Day and reaffirm our commitment to excellence in care.”
To further support patients, HMC collaborates with the Qatar Friends Hemophilia Group, a patient-led advocacy organization that supports education and awareness for both patients and healthcare professionals.
Dr. Ahmed Bahey, Clinical Pharmacist Specialist at Hamad General Hospital emphasised, “On World Hemophilia Day, let's unite to raise awareness about hemophilia, a condition that affects millions. Together, we can advocate for better treatment, empower those living with this disorder, and ensure that no one faces their journey alone. Knowledge is power - let's spread the word and support a brighter future for all affected.”
As part of World Hemophilia Day, HMC, in partnership with the Qatar Friends Hemophilia Group and the Saudi Hemophilia Society, is hosting a series of expert-led awareness sessions featuring local and international speakers. The event aims to promote education, equity, and access to care for individuals living with bleeding disorders.
